entertainment -WSS

entertainment

author：fashion 2025-09-28 01:37:51 - browse：47155

Aduhelm, a pioneering treatment for Alzheimer’s disease that collapsed under corporate mistakes and regulatory controversy, is now a cautionary tale in pharmaceutical history.

This week Biogen said it would no longer sell or study the medicine, which first won approval in 2021, ending an era for one of biotech’s storied companies and leaving the rest of the industry to piece together the lessons of a would-be blockbuster that never took off.

STAT reporters took a stab at the Aduhelm legacy — for biotech, Biogen, and Alzheimer’s research — on a recent episode of the Readout LOUD. Here’s an edited transcript of that conversation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： FDA seeking to stop procedures at two unregulated stem cell clinics

WSS

Ionis drug prevents swelling attacks due to hereditary angioedema

Shifting the focus from loneliness to social health

Letters to First Opinion on caregivers, digital health, and more

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

entertainment

entertainment

Wikipedia

New air purifier tech could be key to improving indoor air quality

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Jerome Adams on the need for new antivirals for Covid

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Jerome Adams on the need for new antivirals for Covid

Why you get paid to donate plasma but not blood

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Medical leaders decry Supreme Court decision on affirmative action

Shifting the focus from loneliness to social health

focus

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

House passes resolution saying Israel isn't a 'racist or apartheid state'

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Letters to First Opinion on caregivers, digital health, and more

Woman returns to dialysis after doctors remove transplanted pig kidney

Ionis drug prevents swelling attacks due to hereditary angioedema

entertainment

Wikipedia

focus

leisure time